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ABSTRACT  
Yeasts, which have been a component of the human diet for at least 7000 years, 
possess an elaborate cell wall -mannan. The influence of yeast mannan on the 
ecology of the human microbiota is unknown. Here we show that yeast -mannan is a 
viable food source for Bacteroides thetaiotaomicron (Bt), a dominant member of the 
microbiota. Detailed biochemical analysis and targeted gene disruption studies 
support a model whereby limited cleavage of -mannan on the surface generates 
large oligosaccharides that are subsequently depolymerized to mannose by the 
action of periplasmic enzymes. Co-culturing studies showed that metabolism of yeast 
mannan by Bt presents a ‘selfish’ model for the catabolism of this recalcitrant 
polysaccharide. This report shows how a cohort of highly successful members of the 
microbiota has evolved to consume sterically-restricted yeast glycans, an adaptation 
that may reflect the incorporation of eukaryotic microorganisms into the human diet. 
  
The microbial community in the human large bowel, the microbiota,1,2 is central to the health 
and nutrition of its host3-6. Glycan utilization is a key evolutionary driver underpinning the 
structure1,2 of this microcosm1,2 with the Bacteroidetes playing a dominant role in this 
process. The genomes of Bacteroidetes contain Polysaccharide Utilization Loci (PULs)7 that 
encode the apparatus required to utilize complex carbohydrates, with each PUL 
orchestrating the degradation of a specific glycan.  
 
The microbiota contains a cohort of bacteria that target -mannosidic linkages8,9,  indicating 
that -mannose-containing glycans, such as yeast and other fungal -mannans are 
significant nutrients for these microbes (see Supplementary Information 1.0). Furthermore, 
these glycans are implicated in the immunopathology of the inflammatory bowel disease, 
Crohn’s disease10,11 (Supplementary Information 2.0). The genome of Bacteroides 
thetaiotaomicron (Bt), a dominant member of the microbiota, encodes 36 proteins predicted 
to display -mannosidase or -mannanase activity12. Here we unravel the mechanism by 
which Bt metabolizes the major -mannose-containing glycans presented to the large bowel. 
The data show that Bt expresses a specific yeast -mannan degrading system that is 
distinct from the high mannose mammalian N-glycan (HMNG) depolymerizing apparatus.  
 
Bt polysaccharide utilization loci dedicated to yeast -mannan degradation 
Bt utilizes -mannan as a sole carbon source and transcriptional studies identified three Bt 
PULs (PUL-Man1, PUL-Man2 and PUL-Man3), Fig. 1a, that were activated by -mannan 
3 
 
from Saccharomyces cerevisiae13, Schizosaccharomyces pombe and the pathogenic yeast 
Candida albicans, Fig. 1b, Extended Data Fig. 1ab. Bt mutants lacking PUL-Man2 or PUL-
Man1/2/3 were unable to grow on yeast mannan (YM) in vitro,  Extended Data Fig. 1c. In 
gnotobiotic mice fed a diet lacking glycans the Bt mutant PUL-Man1/2/3 outcompeted the 
wild type bacterium, while the wild-type strain was the dominant species in rodents fed a 
YM-rich diet, Fig 2a. These data underscore the importance of PUL-Man1/2/3 when Bt is 
exposed to yeast mannan in vivo, while the intriguing dominance of the mutant strain in 
animals fed a polysaccharide-free diet is further considered in Supplementary Information 
3.2. To explore whether Bt degraded -mannan and HMNG13 by distinct enzyme systems, 
the PULs activated by a HMNG, Man8GlcNAc2, were evaluated. A single PUL was activated 
by Man8GlcNAc2, which was distinct from PUL-Man1/2/3, Fig. 1c, demonstrating that 
degradation and thus utilization of -mannan and HMNG are orchestrated by different PULs.  
 
Analysis of the growth profiles of 29 human gut Bacteroidetes species revealed that nine 
species metabolized S. cerevisiae-mannan with 33 out of 34 strains of Bt growing on the 
glycan Fig. 1d. These data show that Bt, along with some of its phylogenetically related 
neighbours, dominates YM metabolism in the Bacteroidetes phylum of the microbiota. Within 
fully-sequenced genomes of 177 microbiota members, the presence of the enzyme families 
(GHs) integral to -mannan degradation (GH38, GH92 and GH76) are restricted to five 
species of Bacteroides and three of Parabacteroides; no Firmicutes contained this grouping 
of GHs8. 
 
Structure of the Bt -mannan degrading PULs 
Bt PUL-Man1 and PUL-Man2 display significant synteny, Supplementary Table 1, while 
PUL-Man3 displays no organizational similarity to the other two loci, Fig. 1a. 
Characterization of the 15 enzymes encoded by the mannan PULs revealed that these loci 
orchestrate -mannan degradation from diverse yeasts and possibly other fungi. For 
example, PUL-Man1 contains an -galactosidase, BT2620, which targets -galactosyl 
linkages absent in S. cerevisiae mannan but present in other fungal -mannans such as the 
yeast Sc. pombe14,  Extended Data Fig. 1d, explaining why inactivation of PUL-Man1 
affects growth of Bt on this polysaccharide,  Extended Data Fig. 1b. Functional diversity is 
also evident in PUL-Man2, which, in addition to its catabolic role, encodes 
glycosyltransferases that mediate synthesis of the trisaccharide Man-1,3-[Man-1,6]-Man,  
Extended Data Fig. 2. Thus, PUL-Man2 comprises a unique example of the co-regulation of 
related catabolic and biosynthetic functions within a single PUL13.  
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-Mannan degradation occurs at the cell surface and in the periplasm 
The enzymatic degradation of-mannan is restricted through steric constraints imposed 
through the side chains appended to the backbone, Supplementary Table 2, Extended 
Data Fig. 1e and 4a. Critically, the -1,6-Man-backbone is not accessible to the endo-1,6-
mannanases until the side chains have been removed, consistent with the topography of the 
substrate binding cleft of these enzymes,  Extended Data Fig. 3ab. The PUL-Man3-
encoded endo-1,2-mannosidase, BT3862, released a limited proportion of the terminal 
Man-1,3-Man disaccharides, thereby assisting in exposing the backbone. The structural 
basis for the specificity displayed by BT3862 is described in Extended Data Fig. 3cd. In 
addition to BT3862, other surface enzymes are required to partially expose the -1,6-Man-
backbone. Screening for such enzymes revealed a -mannosidase, BT2199, that mediates 
very limited extracellular removal of side chains, Extended Data Fig. 4a, and thus facilitates 
limited cleavage of the mannan backbone by the surface endo-1,6-mannanases, BT2623 
and BT3792. The activity profiles of BT2199 and the surface endo-acting mannanases are 
consistent with the observed production of large oligosaccharides by non-growing cells of Bt 
incubated with YM, Extended Data Fig. 4bc.  
  
The cellular location of the key -mannan hydrolysing enzymes, Fig. 2bc, indicates that the 
polysaccharide is degraded primarily in the periplasm where the side chains are removed by 
the synergistic action of -mannosidases and sugar-6-monophosphatases, Extended Data 
Fig. 515, Fig. 2de, Supplementary Tables 2 and 3 and Supplementary Information 4.0. 
The broad specificity of BT3774 enables the -mannosidase to play a key role in the 
removal of the uncharged side chains, being the only enzyme capable of removing the 
sterically-restricted 1,2-Man units linked to the -mannan backbone, Fig. 3 and Extended 
Data Fig. 4f and 5, as well as cleaving the Man-1-phosphate linkage, a critical step in the 
removal of the phosphorylated branches, Fig. 2d. The importance of BT3774 in -mannan is 
consistent with the growth profile of the Bt mutant bt3774, Extended Data Fig. 1d.  
 
Hydrolysis of the 1,6-Man backbone of -mannan by Bt was mediated by surface and 
periplasmic “retaining” endo-1,6-mannanases, Extended Data Fig. 4e. The surface endo-
mannanases BT2623 and BT3792, Fig. 2bc, generated large oligosaccharides, while the 
periplasmic mannanases, BT2631 and BT3782, produced small limit products, Extended 
Data Fig. 6a-c. Consistent with these product profiles, the periplasmic enzymes were ~100 
to 1,000-fold more active than the surface mannanases against oligosaccharides with a 
degree of polymerization (d.p.) <6, while against large oligosaccharides (d.p. ≥6) the 
periplasmic and surface enzymes displayed broadly similar activities, Fig. 2f and 
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Supplementary Table 4. The unadorned 1,6-mannooligosaccharides generated in the 
periplasm were hydrolyzed by the exo--1,6-mannosidases BT2632 and BT3781, Extended 
Data Fig. 6de and Supplementary Table 2, as previously proposed16. The inability of the 
backbone cleaving enzymes to attack wild type yeast -mannan indicates that these 
glycoside hydrolases cannot accommodate -1,6-linked Man decorated at O2 (side chains 
are appended -1,2 to the mannan backbone)in the active site or proximal subsites, 
consistent with the structures of the substrate binding clefts of BT3792 and BT3781, 
Extended Data Fig. 3a-f.  
 
A Bt PUL for HMNG catabolism 
PUL-HMNG encodes four enzymes and two surface glycan binding proteins, Extended Data 
Fig. 7a. BT3990 and BT3991 target 1,2-Man and 1,3-Man linkages, respectively, in 
HMNGs17. The terminal undecorated 1,6-Man exposed by BT3990 is hydrolyzed by 
BT3994, which requires GlcNAc at the reducing end for activity, producing Man-1,6-Man-
1,4-GlcNAc, Extended Data Fig. 7b. BT3987 is a surface endo-acting N-
acetylglucosaminidase, which cleaves the oligosaccharide from its polypeptide, Extended 
Data Fig. 7cd. The released HMNG is held on the surface of Bt through the mannose-
binding protein BT3986, while the SusD homolog, BT3984, by recognizing the reducing end 
GlcNAc, Extended Data Fig. 7ef and Supplementary Table 5, likely orientates the glycan 
into the outer membrane porin (SusC homolog BT3983) for transport into the periplasm, 
where the periplasmic -mannosidases deconstruct the oligosaccharide  into a trisaccharide 
that is degraded by enzymes that are not encoded by PUL-HMNG. A model for the 
enzymatic degradation of HMNG is displayed in Fig. 5. The importance of PUL-HMNG in the 
metabolism of the N-glycan is consistent with the reduced growth of the bt3993 mutant 
(lacking the ECF regulator of PUL-HMNG) cultured on Man8GlcNAc2, Extended Data Fig. 
7g.  
 
Yeast -mannan degradation optimized to reduce nutrient loss 
Substrate promiscuity is a hallmark of the -mannan degradation apparatus of Bt as steric 
constraints limit enzymatic access to the glycan side chains, and consequently the 
polysaccharide backbone. Accordingly, Bt uniquely uses surface -mannosidase(s), likely 
BT2199, to generate limited, but sufficient, side chain removal for the surface endo-acting 
enzymes to mediate infrequent cleavage of the backbone. The Bt mannan degrading 
apparatus is optimized to minimize nutrient loss, illustrated by the observation that no 
oligosaccharides were released into the culture supernatant when Bt was cultured on -
mannan, Extended Data Fig. 4c. 
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Endo-1,6-mannanases are central to the hierarchical degradation of YM, reflecting their 
location and substrate specificities. The surface endo-acting enzymes generate large 
oligosaccharides minimizing extracellular metabolism and loss to other microbiota residents. 
The periplasmic endo-1,6-mannanases generate numerous short oligosaccharides, 
maximizing the substrate available to the periplasmic exo-acting -1,6-mannosidases. This 
“selfish” model is consistent with the inability of Bt to support growth of mannose- and 
mannan backbone-utilizing strains of Bacteroides, on intact S. cerevisiae -mannan, Fig. 4. 
It should be emphasised, however, that the degradation of at least some polysaccharides is 
mediated through synergistic interactions between different members of the microbiota18,19, 
illustrating the diverse mechanisms by which nutrients are utilized in this microbial 
community.  
 
This work provide insights into the adaptation of the microbiota to yeast domestication in the 
human diet reflecting the regular consumption of yeast-leavened bread, fermented 
beverages and products such as soy sauce. Bt, and a limited number of other microbiota-
derived Bacteroidetes, have evolved a complex machinery to digest and metabolize yeast 
cell wall mannans. Phylogenetic analysis suggests that this trait penetrated the human gut 
Bacteroidetes at least twice, once each in the Bacteroides and Parabacteroides. It is also 
possible, however, that close relatives of Bt have gained parts of this complex catabolic trait 
via separate events. Analysis of 250 human metagenomic samples revealed -mannan-
degrading PULs closely related to those from Bt in a majority (62%) of subjects, Extended 
Data Fig. 8, making it more common than culturally-restricted traits like red algal porphyran 
degradation20, but less common than plant cell wall xyloglucan degrading PULs, identified in 
divergent Bacteroides species21,22 (see Supplementary Information 3.3).   
 
The -mannan degrading capacity of Bt is consistent with the bacterium’s “glycan generalist” 
strategy7,12,23, enabling the microorganism to thrive in the competitive environment of the 
microbiota, where the omnivore diet of the host requires rapid adaption to the nutrients 
presented to the distal gut. Many of the organisms in the microbiota produce enzymes that 
attack the major components of the human diet such as starch and pectins. An additional 
survival strategy for some members of the microbiota, such as Bt, is the targeting of low 
abundance, highly complex dietary glycans that are not metabolized by most other 
organisms, exemplified here by YM. With respect to the human host the degradation of -
mannan by Bt may also be relevant to host immune-maladaptation and inflammatory bowel 
diseases such as Crohn’s disease. This work provides insights into a sophisticated -
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mannan degrading apparatus that exists within widespread members of the human 
microbiota, thereby revealing the impact made by the historical domestication of yeast and 
other dietary fungi on the structure of this microbial consortium. 
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FIGURE LEGENDS 
Fig. 1. B. thetaiotaomicron PULs involved in yeast -mannan metabolism, and 
utilization of the glycan in Bacteroidetes. a, Genes encoding known or predicted 
functionalities are color-coded and, where appropriate, annotated according to their CAZy 
family. SGBP; Surface Glycan Binding Protein. b, structures of yeast (S. cerevisiae) mannan 
and HMNG. c, cells were grown on media containing glycans as the sole carbon source 
(n=3 separate cultures per substrate), and susC transcripts derived from PULs that encode 
GH76 and/or, GH92 enzymes were quantified by qPCR. y-axis: fold-change relative to  
glucose grown cells. x-axis labels: genes probed. Inset: levels of susC transcripts derived 
from PUL-Man1/2/3 when Bt was cultured on mannan comprising only the 1,6-Man 
backbone or Candida albicans mannan. Data are averages and standard deviations of three 
biological replicates. d, strains of 29 different bacterial species of Bacteroidetes were 
inoculated into minimal media containing S. cerevisiae mannan as sole carbon source (n=2 
replicate cultures per strain). Growth measured at 48 h at A600nm. Inset: phylogeny of 
Bacteroidetes species; organisms growing on mannan connected by red lines.  
 
Fig. 2. Mannan PULs enable colonization of gnotobiotic mice; key biochemical and 
cellular features of the encoded enzymes. a, colonization of gnotobiotic mice (n=5) by 
wild type Bt (red) and a mutant (black) lacking PUL-Man1/2/3. On day 0 mice were gavaged 
with ~108 CFUs of 50:50 of the two Bt strains and then fed a control diet lacking Bt-digestible 
glycans (green). Left: after 7 days the control diet was supplemented with 1% YM in drinking 
water (pink shading). Middle: identical treatment to the left Panel except no mannan was 
included after day 7 (shaded green). At day 21 mannan in the water was switched between 
the groups in the left and middle panels, indicated by the color panels (pink=mannan, 
green=no mannan). Right: mice fed the control diet (shaded green) were switched to a diet 
containing leavened bread (blue). The average abundance of the mannan utilization mutant 
(black) in mice fed the bread diet compared to the corresponding time points in mice fed the 
glycan-free diet (mean+s.e.m., 81%+1.2 in animals fed the bread diet versus 90%+1.7 in 
mice fed the glycan-free diet; P = 0.00005 by unpaired student's t test). Time points at which 
there was a significant difference between the mutant and wild type Bt on the bread diet 
compared to the glycan-free diet (P < 0.05) are indicated with an asterisk . b, fluorescent 
and light microscopic images of Bt incubated with polyclonal antibodies against BT3792 and 
BT3774. c, western blots of Bt cells cultured on YM that were untreated with proteinase K (0 
h) or incubated with 2 mg/ml proteinase K for 16 h. RP;  recombinant protein. Blots were 
probed with antibodies against the Bt enzymes. Localisation blots and microscopy images 
(b,c) are representative data from three biological replicates. d, e, phosphorylated high 
10 
mannose N-glycan MNN4 and RNAaseB incubated with BT2629 (GH92 -mannosidase), 
BT3783 (phosphatase) or BT3774 (GH38 -mannosidase) and the products analyzed by 
capillary electrophoresis. M5 to M9 lack phosphate and mannose-1-phosphate groups. f, 
catalytic efficiency of the endo-1,6-mannanases against α-1,6-mannooligosaccharides 
(SITable 4 full data). 
Fig. 3. Model of YM deconstruction by Bt. Boxes show examples of bonds cleaved by the 
endo-1,2-mannosidase BT3862, by the -1,3- and -1,2-mannosidase activities displayed 
by BT2629 and BT3784, and the Man-1-P and -1,2-Man linkages targeted by BT3774. 
Structures of the enzymes that play a key role in mannan degradation, colour-ramped from 
the N (blue) to the C (red) terminus; ED Fig. 3 provides. In this model limited degradation 
occurs at the surface and the bulk of glycan degradation occurs in the periplasm. SusC-like 
proteins mediate transport across the outer membrane7.   
Fig. 4. Bacteroides co-culture sharing experiments. Bt was co-cultured with a, b, 
Bacteroides cellulosilyticus WH2 or with c, d, Bacteroides xylanisolvens NLAE-zI-p352 with 
either mannan (a and c) or mannose (b and d) as sole carbon source. Each non-mannan 
user was also cultured on mannan independently. The upper graph in each panel depicts 
the cfu ml-1 of each strain, relative to the cfu ml-1 at inoculation. Total cfu ml-1 were 
determined by colony counts, and the proportion of each bacteria was determined by qPCR 
of marker genes from genomic DNA (shown in the lower graph of each panel). Error bars 
represent s.d. of three biological replicates. 
Fig. 5. Model of HMNG depolymerisation by Bt. The interaction of mannose with the 
surface glycan binding protein (SGBP) is shown, while the binding of the SusD homolog (D) 
to the reducing end GlcNAc directs the N-glycan into the SusC-like (C) porin. In both the 
yeast mannan and the HMNG models the bulk of glycan degradation occurs in the periplasm 
(P) and not on the surface. The likely enzymes involved in the periplasmic degradation of the 
trisaccharide generated by the HMNG-PUL encoded system is addressed in 
Supplementary Information Section 4.3.  
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METHODS 
Biochemical studies 
Producing recombinant proteins for biochemical assays: DNAs encoding the mature 
forms of the enzymes used in this study were amplified by PCR using appropriate primers. 
The amplified DNAs were cloned into NcoI/XhoI, Nco/BamHI, NdeI/XhoI or NdeI/BamHI 
restricted pET21a or pET28a, as appropriate. The encoded recombinants generally 
containing a C-terminal His6-tag although, where appropriate, the His-tag was located at the 
N-terminus of the protein. The GH92 enzymes encoded by PUL-HMNG were cloned in a 
previous study17. To express the recombinant genes encoding the mannan degrading 
enzymes, Escherichia coli strains BL21(DE3) or TUNER, harbouring appropriate 
recombinant plasmids, were cultured to mid-exponential phase in Luria Bertani broth at 37 
°C. This was followed by the addition of 1 mM (strain BL21(DE3)) or 0.2 mM (TUNER) 
isopropyl β-D-galactopyranoside (IPTG) to induce recombinant gene expression, and the 
culture was incubated for a further 5 h at 37 °C or 16 h at 16 °C, respectively. The 
recombinant proteins were purified to >90% electrophoretic purity by immobilized metal ion 
affinity chromatography using TalonTM, a cobalt-based matrix, and eluted with 100 mM 
imidazole, as described previously24.  
Producing recombinant proteins BT3783, BT3792 and BxGH99 for crystallization: 
pET28a expression vectors encoding mature BT3783 (residues 27 to 314) and BT3792 
(residues 155 to 514) were cloned into pET28a via NheI and XhoI sites. The gene encoding 
BxGH99 was constructed from synthesized oligonucleotide fragments (Genscipt, Inc.) and 
also subcloned into pET28a using NdeI and XhoI restriction sites.  Plasmids encoding 
BT3783 and BT3792 were transformed into E. coli BL21(DE3) Star chemically competent 
cells, and grown in LB broth at 37 oC supplemented with 50 g mL-1 kanamycin. Production 
of recombinant BT3783 was induced by the addition of 0.2 mM IPTG at a culture OD600 = 
0.6, and incubation at 16 oC for 16 h. BT3792 was produced using the autoinduction method 
25 by shaking inoculated 0.5 L cultures supplemented with 50 µg mL-1 kanamycin for 36 h at 
37 oC and then 48 h at 20 oC. E. coli BL21 (DE3) cells harbouring the BxGH99-encoding 
plasmid were cultured in 0.5 L ZYM-5052 autoinduction media 25, supplemented with 50 μg 
mL−1 kanamycin, at 37 °C for 8 h, with induction occurring overnight at 16 °C. 
To purify BT3783 and BT3792, cells were harvested by centrifugation and ruptured by 
chemical lysis procedure at 4 oC. Briefly, cells were resuspended in 25 mL of a solution 
consisting of 7 % (w/v) sucrose, 50 mM Tris-HCl (pH 7.5), for 5 min. Lysozyme (Sigma-
Aldrich; 10 mg) was then added and stirred for 10 min. A solution (50 mL) consisting of 0.6 
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% (w/v) Triton-X, 0.6% (w/v) deoxycholate, 20 mM Tris-HCl (pH 7.5) was added and stirring 
continued, after which 5 mM MgCl2 was added followed by addition of DNase (Sigma-
Aldrich) to a final 8.5 µg mL-1. The resulting solutions were then centrifuged for 45 min at 
18,000 rpm.  Similarly, cells harbouring BxGH99 were harvested and resuspended in 50 mM 
NaH2PO4, pH 8.0, 300 mM NaCl, and lysed by sonication.   
BT3783 clarified cell lysates were purified by nickel Sepharose affinity chromatography by 
stepwise elution with imidazole. Positive fractions identified by SDS gel electrophoresis were 
dialyzed into 20 mM Tris pH 8.0 and concentrated to 11.25 mg mL-1 with an Amicon stirred 
ultrafiltration unit model 8200. BT3792 clarified cell lysates were purified via nickel-affinity 
chromatography, and positive fractions were buffer exchanged by dialysis into 25 mM Tris-
HCl (pH 8.0) prior to further purification by anion exchange chromatography. Anion 
exchange purified BT3792 buffered in 25 mM Tris-HCl (pH 8.0), 500 mM NaCl, and 2 mM 
DTT was concentrated using a stirred cell Amicon with a 10kDa cutoff to 20 mg ml-1. For 
BxGH99 soluble lysate (isolated by centrifuging at 18,000 rpm) was applied to a NiSO4-
charged 5 mL HiTrap chelating column (GE Healthcare), pre-equilibrated in the same buffer. 
Protein was eluted in an imidazole gradient, dialyzed, concentrated, and further purified on 
an S75 16∕60 gel filtration column (GE) pre-equilibrated in 25 mM Na-Hepes, pH 7.0, 100 
mM NaCl, 1 mM DTT. 
Binding studies: Affinity gel electrophoresis was used to screen for potential glycan binding 
proteins, following the method described in26 with the target polysaccharide at 1 mg ml-1. The 
binding of proteins to their ligands was quantified by isothermal titration calorimetry (ITC), as 
described previously26. Titrations were carried out in 50 mM Na-HEPES buffer, pH 7.5 at 25 
°C. The reaction cell contained protein at 50 μM, while the syringe contained either the 
oligosaccharide at 10 mM or polysaccharide at 3–5 mg ml-1. The titrations were analyzed 
using Microcal Origin version 7.0 software to derive n, Ka, and ΔH values, while ΔS was 
calculated using the standard thermodynamic equation, RTlnKa = ΔG = ΔH − TΔS.  
Glycoside hydrolase and phosphatase assays: -Mannosidase activity was determined 
by the continuous monitoring of mannose release using a linked enzyme assay system 
purchased from Megazyme International (mannose/fructose/glucose detection kit). The 
reaction was carried out at 37 °C in 50 mM Na-Hepes buffer, pH 7.0 containing 2 mM MgCl2, 
1 mM ATP and 1 mM NADP+, excess concentrations of linker enzymes (hexokinase, 
phosphoglucose isomerase and glucose-6-phosphate dehydrogenase) and 1 mg ml-1 BSA. 
Through linker enzymes glucose-6-phosphate, generated from the released mannose, is 
oxidized by glucose-6-phosphate dehydrogenase with concomitant reduction of NADP+ to 
NADPH, which was monitored at 340 nm using an extinction coefficient of 6223 M−1 cm−1. 
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The polysaccharide substrates used were Saccharomyces cerevisiae -mannans from wild 
type or appropriate mutant strains that produce variants of the polysaccharide (Extended 
Data Fig. 5); these mannans were purified from stationary phase cultures of the yeast grown 
in YEPD medium, as described previously15. The 1,6-mannooligosaccharides, which were 
also used as substrates, were generated as follows: 1 g -mannan from the S. cerevisiae 
mutant mnn2 (comprises the 1,6-mannan backbone with no side chains) was digested to 
completion with the endo-mannanase BT3792. The products were freeze-dried and the 
small mannooligosacchardes (d.p. 2 to 5) were purified on two P2 Bio-gel columns set up in 
series, while the large oligosaccharides, with a d.p. of 6 to 8, were fractionated on two P4 
Bio-gel columns also in series. The columns were run at 0.2 ml min-1 in distilled water. The 5 
ml fractions were evaluated by TLC and those containing the same oligosaccharide were 
pooled. The activity of the endo-mannanases against -mannans was determined in 50 mM 
Na-HEPES buffer pH7.5 containing an appropriate concentration of the polysaccharide 
(ranging from 0.1-6 mg ml-1) and 1 mg/mL BSA. Reactions were incubated for 30 min at 37 
oC and, at regular time intervals, 500 L aliquots were removed and the amount of reducing 
sugar was quantified deploying the dinitrosalicylic acid reagent27 and a standard curve of 
mannose in the reaction conditions used. TLC was also used to provide a qualitative profile 
of the mannooligosaccharides generated by the GH76 endo-mannanases from these 
reactions. Around 4 L of the reaction was spotted on silica gel TLC plates and the plates 
were developed in butanol:acetic acid:water 2:1:1 and carbohydrate products detected by 
spraying with 0.5% orcinol in 10% sulphuric acid and heating to 100 oC for 10 min. Substrate 
depletion assays were used to determine the activity of the endo-mannanases against 1,6-
mannooligosaccharides. Briefly 50 M of the oligosaccharides in 50 mM sodium phosphate 
buffer, pH 7.5, containing 0.1 mg ml-1 BSA (NaP buffer), was incubated with an appropriate 
concentration of enzyme (10 to 500 nM). Aliquots were removed at regular intervals for up to 
1 h and, after boiling for 10 min to inactivate the enzyme, the amount of the substrate 
mannooligosaccharide remaining was quantified by HPAEC using standard methodology. 
Briefly, the reaction products were bound to a Dionex CarboPac PA-200 column equilibrated 
with 100 mM NaOH. Mannose and mannooligosaccharides were eluted with a 0-200 mM 
sodium acetate gradient in 100 mM NaOH at a flow rate of 0.25 ml min-1, using pulsed 
amperometric detection. The data were used to determine catalytic efficiency (kcat/KM) as 
described previously28. To determine the activity of the GH99 endo-1,2-mannosidase 
BT3862, the enzyme was incubated with Man-1,3-Man-1,2-Man-1,2-Man-1-CH3. and, in 
combination with the 1,2-mannosidase BT3990, mannose release was monitored using the 
continuous assay described above (BT3990 is active on the product of  BT3862, Man-1,2-
Man-1,2-Man-1-CH3). The activity of BT3862 against aryl-mannosidases was as described 
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previously29. A strategy deploying 2-aminobenzamide (2-AB) labelled glycans at the 
reducing end, using the Sigma GlycoProfile™ 2-AB labelling kit as per the manufacturer’s 
instructions, was used to determine the catalytic efficiency of BT3994. The enzyme (100 nM) 
was incubated with 5 M Man5GlcNAc2 (generated by treating Man9GlcNAc2 with BT3990 an 
1,2-mannosidases) or Man3GlcNAc2 (generated from Man5GlcNAc2 by treating with 
BT3991, 1,3-mannosidase17) in NaP buffer for up to 1 h. Aliquots were removed at regular 
intervals and the amount of glycan remaining was determined using HPAEC and a 
fluorometric detector.. A similar strategy, deploying labelled glycans in harness with HPAEC 
and fluorescence detection was used to measure the endo--N-acetylglucosaminidase 
activity of BT3987 against Man9GlcNAc2. The activity of the enzyme was also evaluated 
against glycoproteins using mass spectrometry using MALDI-TOF mass spectrometry as 
described below. BT2630 and BT3783 were assayed for phosphatase activity using the 
EnzChek Phosphate Assay kit to detect the release of phosphate from appropriate 
phosphorylated sugars. Prior to these assays the two proteins were treated with EDTA and 
the chelating agent was removed using a PD10 column. The assays were carried out in 50 
mM Na-HEPES buffer, pH 7.5, containing 1 mM of MgCl2 or another divalent ion. In this 
discontinuous assay aliquots were removed at regular intervals, the enzyme was inactivated 
by boiling and phosphate release determined.  
The specificity of enzymes against phosphorylated and neutral high mannose N-glycans was 
assessed by capillary electrophoresis. The methodology was essentially that described by 
Tiels et al.30. The two substrates were MNN4 (phosphorylated high mannose N-glycans 
released from glycoproteins expressed by a genetically modied strain of Yarrowia lipolytica) 
and N-glycan from RNAase B (primarily high mannose N-glycans), which were released 
from their respective glycoproteins with PNGaseF. The N-glycans were labelled at the 
reducing end with 8-aminopyrene-1,3,6-trisulfonic acid31, and incubated overnight at 30 oC 
with ~2 M of enzyme in 10 mM Na-Hepes buffer, pH 7.0, containing 2 mM CaCl2. The 
reactions were analyzed by capillary electrophoresis with laser-induced fluorescence 
detection (CE-LIF) using an ABI 3130 capillary DNA sequencer as described previously31 
 
Mannosyl-transferase assays:   BT3775 and BT3776 at 30 M were screened for activity 
using mannose and all possible -mannobiose acceptors at a concentration of 10 mM. 
Reactions were performed in 10 mM Na-Hepes buffer, pH 7.5, 10 mM MnCl2, 50 mM GDP-
Mannose at 37 ºC over time course intervals of 0 min, 5 min, 15 min, 30 min, 60 min, and 16 
h. Reactions were stopped by boiling for 10 min. To explore the synergy between the two 
GT32 glycosyltransferasess, reactions were performed with BT3775 and BT3776 
simultaneously using mannose as an acceptor, and in a step-wise progression with BT3775 
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and mannose as the acceptor, followed by BT3776 on the purified products of the initial 
BT3775 reaction. Enzyme concentrations were maintained in both conditions at 30 M.  
 
MALDI-TOF MS of reaction products: To permethylate N-glycan fragments and 
mannooligosaccharides appropriate enzyme reactions were freeze-dried and suspended in 
dry DMSO (200 l). Oligoglycans were per-O-methylated using standard methods32. Freshly 
prepared sodium hydroxide base in dry DMSO (300 l) and then iodomethane (150 l) was 
added to each sample. The tube was purged with nitrogen and vortexed vigorously. 
Permethylated oligosaccharides (PMOs) were extracted in 2 mL water. After removing 
excess iodomethane (CH3I), 2 mL dichloromethane was added and vortexed to extract 
lipophilic components. The aqueous layer was removed after centrifugation. This was 
repeated 5 more times. After final rinse, the dichloromethane layer was transferred into a 
fresh tube and dried down under N2 stream. The samples were then dehydrated and 
dissolved in 50% aqueous methanol and loaded onto C18 reverse phase resin (100 mg/1 
mL, Resprep™ SPE Cartridges) and eluted with acetonitrile (AcN). AcN washes were dried 
down under N2 and dissolved in 20 L methanol. Equal volumes of the sample and 2% 
DHBA in aqueous methanol, which was used as the matrix, were combined in a separate 
microfuge tube and loaded on the MALDI-TOF MS plate. MALDI-TOF MS analyses were 
performed with an AB4700 MS instrument (Applied Biosystems) in positive ion, reflector 
mode with 100 shots taken per spectrum. PMO mass values were queried online 
(http://www.expasy.org/tools/glycomod/) by GlycoMod tool that can predict possible 
oligosaccharide structures that occur on proteins from their experimentally determined 
masses. 
NMR analysis of glycosyltransferase reaction products: The mannooligosaccharide 
products were separated by size exclusion chromatography on a Superdex-75 
HR10/30column using a Dionex Ultimate 3000 HPLC equipped with a ShodexRI-101 
refractive index detector. The column was eluted with water and fractions were collected and 
freeze-dried. The lyophilized fraction containing the trisaccharide was dissolved in D2O (0.3 
mL, 99.9%; Cambridge Isotope Laboratories) and one- and two-dimensional NMR spectra 
were recorded at 298 K with a Varian Inova NMR spectrometer operating at 600 MHz 
equipped with a 3-mm NMR cold probe. The homonuclear (gCOSY, TOCSY and NOESY) 
and the hetereonuclear (gHSQC and gHMBC) experiments were recorded using standard 
Varian pulse programs. Chemical shifts were measured relative to internal acetone (δH 
2.225). Data were processed using MestReNova software (Universidad de Santiago de 
Compostela, Spain). Interglycosidic scalar couplings observed in the gHMBC spectra were 
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used to determine the sequence and glycosidic linkages of the mannosyl residues in the α-
Man-(1,3)-[α-Man-(1,6)]-Man trisaccharide product. 
 
Linkage analysis of GT32 glycosyltransferase mannooligosaccharide products: 
Overnight incubations were boiled for 5 min and then centrifuged to pellet denatured protein. 
A 200 g aliquot of the sample was suspended in 200 l DMSO and magnetically stirred for 
5 d.  The sample was then permethylated by the method of Anumula and Taylor33. Two 
hundred L of the NaOH base were added and, after 10 min, 100 L CH3I were added and 
the sample was stirred for 40 min. An additional 200 L base and 100 L CH3I were then 
added and stirring was continued for 40 min. The reaction was worked up by addition of 2 
mL H2O, removal of excess CH3I by sparging with N2, and CH2Cl2 extraction. The 
permethylated material was hydrolyzed using 2 M TFA (2 h in a sealed tube at 121 C), 
reduced with NaBD4, and acetylated using Ac2O/TFA.  The resulting partially methylated 
alditol acetates were analyzed on a Hewlett Packard 5890 GC interfaced to a 5970 MSD 
(mass selective detector, electron impact ionization mode); separation was performed on a 
30 m Supelco 2330 bonded phase fused silica capillary column.  
 
Stereochemistry of endo-1,6-mannanases: A solution of BT3792 (25 mg, approx 400 
mole) in buffered D2O (0.25 mL, 50 mM phosphate-citrate, 200 mM NaCl, pD 6.0) was 
added to a solution of 4-nitrophenyl -D-mannopyranosyl-1,6--D-mannopyranoside (4.1 mg, 
0.0086 mmol) in D2O (0.75 mL, 50 mM phosphate-citrate, 200 mM NaCl, pD 6.0) at 22 °C. 
The course of the reaction was monitored by 1H NMR (500 MHz) to identify the 
stereochemistry of the reaction by analyzing the appearance of the anomeric - and -
proton signals. Signals were assigned by 2-D NMR analysis (HSQC). 
 
Growth and transcriptomic studies, whole cell enzyme assays and metagenomic 
database searching 
Bacteroides culture and whole cell assays: Bt was cultured anaerobically at 37 °C in 
minimal media containing an appropriate carbon source. or in TYG (tryptone yeast extract 
glucose medium) as described previously21. Growth curves presented in the paper are 
averages of six biological replicates. Bt was grown in 5 mL minimal media on 0.5% w/v 
Saccharomyces cerevisiae mannan (Sigma) or glucose as the sole source to mid 
exponential phase (OD600nm 0.6-0.8). Cells were harvested by centrifugation, 5000 x g 10min 
at room temperature and washed in 5 ml Phosphate buffered Saline pH 7.1 (PBS) before 
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being resuspended in 500 μL PBS. Cells (50 μL) were assayed against yeast mannan (10 
mg ml-1) at 37 °C for 16 h. Assays were analysed by thin layer chromatography, 5 μL of each 
sample was spotted onto silica plates and resolved in butanol/acetic acid/water buffer. The 
plates were dried and sugars visualised by orcinol/sulphuric acid heated to 70°C.  
 
Cellular localization: Cultures of Bt (100 mL) were grown in minimal media on yeast 
mannan (0.5% w/v) as a sole carbon source, to mid exponential growth phase (OD600nm 0.6-
0.8). Cells were harvested by centrifugation and washed in 10 mL PBS before being 
resuspended in 5 mL of the buffer. The cells were split into four 1 mL aliquots. To 3 of the 
aliquots 2 mg ml-1 Proteinase K was added and incubated at 37° C for 1-16 h, the fourth 
sample was left as an untreated control also for 16 h. Following incubation with the protease 
the samples were centrifuged at 5000 x g for 10 min and the supernatant discarded. The cell 
pellets were resuspended in 1 ml PBS and the proteins precipitated by the addition of 200 
μL trichloroacetic acid and incubation on ice for 30 min. The precipitated proteins were 
pelleted by centrifugation and washed 4 times in 1 mL ice cold acetone. The protein pellets 
were resuspended in 250 μL Laemmli buffer and subjected to SDS/PAGE.  Gels were 
transferred to Whatman Protran BA 85 nitrocellulose membrane. Proteins of interest were 
detected using anti-sera raised against the corresponding protein. The secondary antibody 
used was a chicken-anti rat conjugated to horseradish peroxidase. Antibodies were detected 
by chemi-luminescence using Biorad Clarity Western ECL Substrate.  
 
Immunofluorescence microscopy: Bt suspensions (OD600nm = 0.8) in phosphate-buffered 
saline, pH 7.0 (PBS), were applied to clean Eppendorf tubes, fixed by an equal volume of 2 x 
formalin (9% formaldehyde in PBS), and rocked for 90 min at 25 °C. The cells were then 
pelleted by centrifugation for 3 min at 7000 x g and washed twice with 1 ml of PBS. Bacterial 
cell pellet was resuspended in 1ml of blocking solution (2% goat serum, 0.02% NaN3 in 
PBS) and incubated at 4 °C for 16 h. After incubation cells were centrifuged again at 7000 x 
g and the supernatant discarded. For labelling, the bacteria were incubated with 0.5 ml of 
primary rat IgG (1/500 dilution of IgG in blocking solution) for 2 h at 25 °C. The cells were 
then pelleted, by centrifugation, washed in 1 ml of PBS and resuspended in 0.4 ml goat anti-
rat IgG Alexa-Fluor 488 (Sigma), diluted 1/500 in blocking solution, and incubated 1 h at 25 
°C in the dark. The cells were then pelleted, washed with PBS and resuspended in 50 l of 
PBS containing ProLong Gold antifade reagent (Life Technologies). Labelled bacterial cells 
were mounted onto glass slides and secured with coverslips. Fluorescence was visualized 
using a Leica SP2 UV microscope (Leica Microsystems, Heidelberg, GmbH) with x63 na1.32 
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lens. Alexa-Fluor 488-labelled bacteria were viewed under a UV microscope view and 
compared with bright-field phase-contrast of the same image. 
 
Constructing mutants of the yeast mannan and HMNG PULs in B. thetaiotaomicron: 
The inactivation of the HMNG-PUL ECF regulator was described previously13. The other 
mutants deployed in this study, PUL knock outs and single gene clean deletions were 
introduced by allelic exchange using the pExchange vector as described in Koropatkin et 
al.34 The use of quantitative reverse transcriptase PCR to quantify appropriate transcripts 
followed the methods described by Martens et al.13.  
Gnotobiotic mice experiments: All animal experiments were approved by the University 
Committee on Use and Care of Animals at the University of Michigan and were supervised 
by a veterinarian. Germ-free mouse experiments were conducted in a total of 24, 6–8-week-
old male and female Swiss Webster mice (each was considered to be a single biological 
replicate in its respective experiment and treatment group). Mice were randomly assigned 
into groups by a technician who was not familiar with the project. The investigators were not 
blinded to the identities of the treatment groups during the experiment and no data were 
excluded from the final analysis. For in vivo gene expression studies, mice were randomly 
grouped into three groups containing three animals each, and then subjected to three 
different dietary regiments. Two groups were fed a gamma-irradiated custom diet (glycan-
free diet) that contained only glucose as the available carbohydrate as well as cellulose, a 
polysaccharide that cannot be degraded by Bt, as a non-digestible fiber supplement35. One 
of the two groups maintained on this diet was provided with purified -mannan (1% w/v) in 
drinking water (Harlan-Teklad). The third group was fed a custom version of the 
polysaccharide-free diet in which the glucose was replaced with dried/crumbed bread (50% 
w/w of final diet) that had been produced using yeast as a leavening agent (Zingerman's 
Bake House, Ann Arbor, MI). Mice were pre-fed on each dietary condition for five days, 
colonized with Bt by oral gavage (~108 cfu/animal) and maintained for an additional 5 days 
before sacrifice and collection of cecal contents for gene expression analysis. For the in vivo 
competition experiment, wild-type and mannan PUL triple mutant strains were each labeled 
with a unique 24 bp oligonucleotide tag, which is contained in a pNBU2-based chromosomal 
integration vector and quantifiable by qPCR, as previously described.13 Each strain was 
grown overnight in TYG medium and combined at approximately equal amounts prior to 
being gavaged into mice as described above. For competition experiments, 5 mice were 
used in each group (chosen based on the sample size used in previous studies to observe 
significant changes in competitive index18,28) and fed varying regimens of the three diets 
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described above for a total period of 38 days. All germfree mice used in the competition 
experiment were pre-fed the glycan-free diet for one week prior to colonization. 
Bacteroides co-culturing experiments: Bt, B. xylanisolvens NLAE-zl p352  and B. 
cellulosilyticus WH2  were cultured in minimal media containing glucose (0.5% w/v) as a 
carbon source to mid exponential growth phase (OD600 0.7-0.8) . Cells were harvested by 
centrifugation and washed twice with 5 ml of PBS to remove any residual glucose. The 
washed cells were resuspended in 5 ml of fresh minimal media with no carbon source. 
Minimal media (10 ml) containing mannose or yeast mannan as the carbon source was 
inoculated with equal volumes of Bt/B. xylanisolvens or Bt/B. cellulosilyticus. A control 
culture of minimal media containing yeast mannan was also inoculated with either B. 
xylanisolvens or B. cellulosilyticus. All cultures were set up in triplicate. Samples (1 ml) were 
taken at the point of inoculation, early exponential, late exponential and stationary phase of 
growth. Serial dilutions of each sample were plated on to rich media and incubated for 2 
days before colony counts were recorded. Proportions of Bt, B.xylanisolvens  and 
B.cellulosilyticus  per sample were determined by quantitative PCR from genomic DNA using 
unique marker genes for each strain.  
Searches of human gut metagenomic datasets for mannan PULs: A search of 250 
different healthy and diseased (Crohn's disease and ulcerative colitis) human metagenomic 
samples was conducted exactly as described previously35. Probes corresponding to the 
three Bt mannan PULs were first checked against database of complete and draft microbial 
genome sequences to identify regions that were present in species other than Bt, or the 
porcine B. xylanisolvens strains in the case of PUL-Man1. In the case of PUL-Man2 and 
PUL-Man3, the entire sequence was determined to be specific for sequenced Bt isolates; 
whereas, PUL-Man1 was trimmed to a region containing 15.059 kb that were unique to Bt 
and porcine B. xylanisolvens. The three probes used correspond to the following basepair 
coordinates in the Bt VPI-5482 genome sequences: PUL-Man1 (3262908..3277966), PUL-
Man2 (4893415..4928241) and PUL-Man3 (5012915..5031551). 
Crystallization, Data Collection, Structure Solution and Refinement: 
3.1 Crystallization: BT3783 and BT3792 were crystallized using the sitting drop vapor 
diffusion method at 18 oC. BT3783 crystals were obtained by mixing equal volumes of 
purified, recombinant BT3783 protein at a concentration of 11.25 mg mL-1 with mother liquor 
solution consisting of 15% (w/v) polytheylene glycol 4,000, 5% (±)-2-methyl-2,4-pentanediol 
(v/v), 3 mM D-mannose, and 200 mM MgCl2. Crystals of BT3792 were obtained by mixing 
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equal volumes of purified recombinant BT3792 at a concentration of 20 mg/ml buffered in in 
25 mM Tris-HCl (pH 8.0), 500 mM NaCl, 2 mM DTT with a reservoir solution consisting of 
5% glycerol (v/v), 24% (w/v) polyethylene glycol 2,000 monomethyl ether, 0.25 M sodium 
acetate, and Bis-Tris-HCl (pH 5.5). Large, thin plate crystals of BT3792 developed over a 
period of 5 days to a week. BT3792 crystals were cryoprotected in crystallization solutions 
supplemented with 25% ethylene glycol and cryo-cooled directly in a N2 stream at -160 oC 
prior to diffraction experiments.  
BxGH99 crystals were grown at 19 °C using hanging-drop vapour diffusion with equal 
volumes of protein (30 mg ml-1) and reservoir solution consisting of 0.1 M sodium acetate pH 
5.1, 20% w/v PEG 2000 MME (mono-methyl ether), 2.0% PGA-LM (poly-γ-glutamic acid low 
molecular weight).  Ligand complex formation as a ternary with Man-IFG and α-1,2-
mannobiose, was achieved by soaking native BxGH99 crystals in mother liquor 
supplemented with approximately 10 mM of respective ligand solutions for a period of 30 
minutes prior to flash cooling in liquid N2.  Crystals were cryo-protected by the stepwise 
addition of ethylene glycol, supplemented with appropriate ligand(s), to a final concentration 
of 20% v/v. 
3.2 Data Collection, Structure Solution and Refinement: Diffraction data from both 
BT3783 and BT3792 crystals were collected at the Canadian Lightsource beamline 08B1-1 
(CMCF-BM) in oscillation mode (λ = 0.97961 and 0.98005 Å, with data collected at 100 K 
respectively). The BT3783 and BT3792 datasets were processed with iMosflm36,37 and XDS 
38, respectively, and both were scaled with SCALA37. BT3783 and BT3792 structures were 
solved by molecular replacement with the program Phaser MR 39 using the coordinates of 
apo BT3783 (PDBID: 3MPR) and the coordinates of Lin0763 from Listeria innocua (PDBID: 
3K7X). The asymmetric unit of BT3783 and BT3792 contain four and two protein molecules, 
respectively. The structures were subsequently improved with cycles of manual building with 
COOT40 and refinement with REFMAC37. Five percent of the reflections were flagged as 
“free” to monitor the refinement process. The structure of BT3783 extends from residues 26-
309 with a magnesium ion coordinated in the putative active centre. The structure of BT3792 
runs continuously from residue 151-525. Due to a lack of continuous density corresponding 
to this polypeptide region, residues 274-290 are absent in the model of BT3783. BT3792 
structural refinement required amplitude correction for twinning. The final refined structures 
were validated with the aid of Molprobity41.  Final BT3783 and BT3792 structures featured, 
respectively, 94.8 and 99.6% of all modeled residues within the Ramachandran “favored” 
region, with a further 4.2 and 0.4% within the “additional allowed” region. 
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Diffraction data for the BxGH99-Man-IFG-mannobiose ternary complex were collected at 
beamline I03 (λ = 0.97625 Å, data collected at 100 K) of the Diamond Light Source, Didcot, 
UK.  The datasets were processed using XDS38 and AIMLESS 42 (also within CCP437).  
Phases were derived from a previously solved (native) BxGH99 atomic model, with initial 
refinement conducted using REFMAC37.  Calculated electron density maps were visually 
assessed for evidence of ligand-binding, with subsequent completed atomic models, 
featuring appropriately assigned ligand coordinates, refined to convergence through 
numerous cycles of REFMAC37 and additional manual correction using COOT40.  The final 
BxGH99 ternary structure featured, respectively, 96.5 and 96.9% of all modeled residues 
within the Ramachandran “favored” region, with a further 2.3 and 1.9% within the “additional 
allowed” region. Data collection and refinement statistics for all structures are presented 
below in Supplementary Table 6. 
Accession Codes: Coordinates and structure factors for BT3783-Mg binary complex, 
BT3792 and the BxGH99/Man-IFG/mannobiose ternary complex have been deposited in the 
protein data bank with the accession codes 4C1R, 4C1S and 4UTF respectively. 
Experimental group size and statistical analysis of data 
For all quantitative enzyme assays at least three technical replicates were performed unless 
specifically stated in the Table legends. Standard errors of the mean are stated for kinetic 
parameters in Supplementary Tables 2, 3 and 4. For Table 5 the kinetic parameters are 
reported ± the error of the fit of the data using linear regression. For isothermal titration 
calorimetry experiments three technical replicates were performed for each titration. 
Standard errors of the mean are shown in Supplementary Table 5. In the Gnotobiotic mice 
experiments displayed in Figure 2A five mice were assigned to each diet and the error bars 
for the two bacterial strains respresent standard errors of the mean. Statistical significance of 
the persistence of different strains of Bt in the same mice was analysed by unpaired 
student's t test. For the microbial sharing experiment detailed in Figure 4 the error bars 
represent standard deviations of the mean from three biological replicates.   
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Extended Data Fig. 1. The role of specific Bt PULs and enzymes in utilization of 
mannan from S. cerevisiae and other yeast species. a, growth of wild type Bt on Candida 
albicans mannan and glucose. b, growth of wild type Bt and the mutant lacking PUL-Man1 
and PUL-Man3 (PUL-Man1/3) on Schizosaccharomyces pombe -mannan. c, growth of 
wild type Bt, and the Bt mutants lacking Pul-Man2 (PUL-Man2), or all three mannan PULs 
(PUL-Man1/2/3) on S. cerevisiae -mannan. d, displays the growth profile of wild-type Bt 
and the Bt mutant lacking bt3774 (bt3774) on S. cerevisiae mannan. In panels a, b, c and 
d, each point on the growth curve represents the mean of three biological replicates. e, 
enzymes at 1 M at 37 oC were incubated with either undecorated -1,6-mannan (derived 
from mnn2 mutant of S. cerevisiae), lanes 1-3, or mannan from S. pombe, lanes 4-9. Lanes 
1 and 4, the mannans incubated in the absence of the enzymes; lanes 2 and 6, mannans 
incubated with the periplasmic mannanase BT3782, and in lanes 3 and 7 the surface 
mannanase BT3792; lane 5, S. pombe mannan incubated with the GH97 -galactosidase 
BT2620; lanes 8 and 9, S. pombe mannan incubated with BT2620/BT3782 and 
BT2620/BT3792, respectively. Lane 10 galactose standard; lane 11-1,6-
mannooligosaccharides: mannose (M1), mannobiose (M2), mannotriose (M3) and 
mannotetraose (M4). 
Extended Data Fig. 2. Product profiling of GT32 glycosyltransferases encoded by 
PUL-Man2. a, HPAEC of biosynthetic reactions using mannose as an acceptor and GDP--
Man as the donor. Mannobiose is formed in the presence of BT3775 (black) and 
mannotriose with BT3775 and BT3776 (red). The blue trace is a mannose 
standard. b, HPAEC of biosynthetic reactions with 1,3-mannobiose as the acceptor and 
GDP--Man as the donor. BT3775 is not capable of extending mannobiose (black). In the 
presence of BT3775 and BT3776 mannotriose is produced (red). The blue trace is an 1,3-
mannobiose standard. MALDI-TOF analysis of the reaction products of BT3775 + BT3776 
using c, mannose and d, 1,3-mannobiose as an acceptor. e, NMR analysis of the 1,3-
mannobiose substrate. Peaks (1) and (3) correspond to the -anomer and -anomer of the 
mannose at the reducing end, respectively; peak (2) corresponds to the terminal α-mannosyl 
residue linked to O-3 of the mannose at the reducing end. f, NMR analysis of 
the 1,3,(1,6)-mannotriose BT3776 product. The numbering of the peaks are the same as 
in e. Peak 4 corresponds to the terminal α-mannosyl residue linked to O-6 of the 3,6-linked 
mannose at the reducing end. g, alditol-acetate linkage analysis of mannobiose produced 
by BT3775 from mannose. h, alditol-acetate linkage analysis of branched (1,3),(1,6)-
mannotriose produced by BT3776 from 1,3-mannobiose. The green circles indicate the 
mannose residues present in carbohydrates identified by HPAEC, MALDI-TOF and NMR. 
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Extended Data Fig. 3. The structures of enzymes that play a key role in yeast mannan 
degradation. a, overlay of the hydrophobic conserved residues in the predicted substrate-
binding cleft of BT3792 (yellow), BT2949 (cyan) and the Listeria protein Lin0763 (green; 
PDB code 3K7X), and the predicted catalytic aspartates. b, solvent representation of 
BT3792 in which the predicted catalytic residues, Asp258 and Asp259, are coloured green. 
c, overlay of BT3862 (cyan) with a homolog of the enzyme from B. xylanisolvens, BxGH99 
(green; PDB code 4UTF) in complex with Man-1,3-isofagomine and -1,2-mannobiose 
(Man residues coloured yellow and isofagomine pink). d, solvent exposed surface of the 
substrate binding cleft of the BxGH99 (teal) ligand complex overlaid with BT3862 (grey). The 
subsites are numbered with the catalytic residues, Glu333 and Glu336, coloured red and the 
solvent exposed O2 of Man bound at the -2 subsite and O1 and O6 of the Man located at the 
+2 subsite are coloured bright green. e, overlay of BT3781 (green; PDB code 2P0V) with the 
substrate and catalytic residues of the Clostridium perfringens GH125 -mannosidase 
CpGH125 (cyan; PDB code 3QT9), in which the ligand 6-S--D-mannopyranosyl-6-thio-a-D-
mannopyranose (Man-S-Man) is shown in yellow. f, solvent exposed surface of BT3781 in 
the vicinity of the active site in which the catalytic residues (Glu174 and Glu439) are 
depicted in green. The position of Man-S-Man is based on the overlay shown in e. g, overlay 
of BT3783 with the catalytic and substrate binding residues of a tyrosyl-DNA 
phosphodiesterase (PDB code 4GYZ) in complex with Mg2+ (slate blue sphere) and 
phosphate (coloured orange). h, a region of the solvent accessible surface of BT3783 in 
which the catalytic residues are coloured green. The figure was prepared using PyMOL. A 
detailed description of the structures of these proteins is provided in Supplementary 
Information Section 5.  
Extended Data Fig. 4. The degradation of yeast mannan by Bt in culture and the 
selected enzymes expressed by the bacterium, and the stereochemistry of the 
reaction catalyzed by GH76 endo-1,6-mannanases. a, GH92 -mannosidases at high 
concentrations (50 M) were incubated with yeast mannan for 5 h in the absence (labelled 
GH92) or in the presence (GH92/GH76) of the endo-1,6-mannanase BT3782. The GH92 
-mannosidases in this example were BT2199 (1), BT2130 (2) and BT3773 (3). The GH76 
endo-1,6-mannanase only releases mannooligosaccharides in the presence of BT2199; 
see also Supplementary Information Section 4.1. b, Bt was grown on yeast mannan or 
glucose. Yeast mannan was incubated with no bacterium (1), Bt previously cultured on yeast 
mannan (2) and Bt grown on glucose. The cells were incubated for 5 h at 37 oC with the 
polysaccharide without a nitrogen source and thus were not growing. The products released 
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by the Bt cells, analysed by TLC, were mediated by the activity of enzymes presented on the 
surface of Bt, and not through the action of periplasmic mannanases and mannosidases. 
The black box highlights very low levels of high molecular weight mannooligosaccharides 
generated by the cells incubated in yeast mannan. c, Bt was cultured for up to 48 h 
(stationary phase) on yeast mannan. The supernatant of the culture at the time points 
indicated were analyzed by TLC. In all panels the samples were chromatographed with the 
following 1,6-mannooligosaccharides: mannose (M1); mannobiose, M2; mannotriose, M3; 
mannotetraose, M4. d, the absorbance of the culture used in C. e, BT3792 (GH76) endo--
1,6-mannosidase is a retaining glycoside hydrolase. Enzymatic hydrolysis of 4-nitrophenyl -
D-mannopyranosyl-1,6--D-mannopyranoside (S) was monitored by 1H-NMR spectroscopy 
(500 MHz). The stacked spectra show the reaction progress over time. SH1 is the anomeric 
proton of the reducing end mannopyranoside of the substrate, and SH1’ is the anomeric 
proton of the non-reducing end mannopyranoside. The reaction proceeds with the initial 
formation of the product, the -anomer of -1,6-mannobiose (P-, peaks PH1 and PH1’), 
which slowly mutarotates to the -anomer (P-, peaks PH1 and PH1’). f, TLC analysis of S. 
cerevisiae mannan incubated without enzyme (lane 1), BT3774 (lane 2), BT3792 (lane 3, 
BT3774 and BT3792 (lane 4). M1-M4 are -mannnooligosaccharide standards numbered 
according to their d.p. f, GH76 mannanase BT3792 does not attack the backbone of S. 
cerevisiae mannan unless the side chains are first removed by the GH38 -mannosidase 
BT3774, confirming that this enzyme cleaves the mannose linked -1,2 to the mannan 
backbone. The data in a, b and c are representative of two biological replicates, while the 
data in f are representative of two technical replicates. 
Extended Data Fig. 5. The activity of periplasmic -mannosidases and the growth of 
different species of Bacteroides against yeast mannan. Structures of the mannans 
derived from wild type and mutants of S. cerevisiae. The tables adjacent to the different 
yeast structures depict the initial rate of mannan hydrolysis by the four enzymes. The growth 
curves adjacent to the different mannan structures show the growth profile of Bt (black), B. 
ovatus (red) and B. xylanisolvens (blue) on the glycans (each point represents the mean 
growth of 3 separate cultures + s.d.). The porcine-derived B. xylanisolvens strain shown 
here acquired PUL-Man1 by lateral gene transfer, Extended Data Fig. 9, explaining its 
capacity to degrade processed mannans.  Vertical error bars represent standard deviation of 
three separate replicates in each condition.  
Extended Data Fig. 6. The activity of GH76 -mannanases and GH125 -mannosidases 
a, b, BT3792 and BT3782, respectively, were incubated with 1,6-mannotetraose at a 
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concentration <<KM. Substrate depletion was measured using HPAEC and the rate (right 
hand of a and b) enabled kcat/KM to be determined. c, BT3792 and BT3782 were incubated 
with unbranched yeast mannan (derived from the S. cerevisiae mutant MNN2). The yeast 
mannan at 1% was incubated with the two GH76 1,6-mannanases for 1 h at 37 oC in 50 
mM sodium phosphate buffer, pH 7.0. The limit products were analyzed by TLC. d, e, 
BT2632 and BT3781 at 100 nM were incubated with 1 mg/ml of the debranched mannan for 
1 h in the buffer described above. d displays TLC analysis of the reactions, while e shows 
HPAEC traces. 1,6-Mannooligosaccharides identified by their degree of polymerization 
(M1, mannose; M2, mannobiose; M3, mannotriose; M4, mannotetraose) and IP is the 
injection peak. The data in c and d are representative of two technical replicates. 
Extended Data Fig. 7. HMNG deconstruction by Bt. a, Structure of the HMNG PUL. 
Genes drawn to scale with its orientation indicated. Genes encoding known or predicted 
functionalities are color-coded and, where appropriate, are also annotated according to their 
CAZy glycoside hydrolase family (GH) number. SGBP represents a Surface Glycan Binding 
Protein. b, BT3994 was incubated with 1,6-mannotetraose (Man4-AB) or the high mannose 
N-glycan Man5GlcNAc2, with both oligosaccharides labelled with 2-aminobenzamide (AB). At 
the indicated time points aliquots were removed and analysed by HPAEC using a 
fluorescence detection system. While Man5GlcNac2-AB was hydrolyzed by BT3994, the 
enzyme was not active against Man4-AB. c, chicken ovalbumin was incubated with buffer (1) 
or 1 M of BT3987 (2) in 20 mM Na-HEPES buffer, pH 7.5, for 5 h at 37 oC, and the soluble 
material was permethylated and analyzed by MALDI-TOF mass spectrometry. The high 
mannose N-glycans released are labelled. d, depicts a western blot of Bt cells cultured on 
yeast mannan that were untreated with proteinase K (0 h) or incubated with 2 mg/ml 
proteinase K for 16 h (16 h). The lane labelled RP contained purified recombinant form of 
BT3990. The blots were probed with antibodies against BT3990. The data in d are 
representative of two biological replicates. e,  representative isothermal calorimetry titrations 
(ITCs) for BT3984 titrated with Gal-1,4-GlcNAc (LacNAc; (25 mM), and f, for BT3986 
titrated with mannose (50 mM). The top half of each panel shows the raw ITC heats; the 
bottom half, the integrated peak areas fitted using a one single binding model by MicroCal 
Origin software. ITC was carried out in 50 mM Na/HEPES, pH 7.5 at 25 °C. The affinities 
and thermodynamic parameters of binding are showing in Supplementary Table 5. g, 
shows the growth profile of wild type Bt (WT Bt; black) and the mutant bt3993 (red), which 
lacks the ECF-regulator gene of PUL-HMNG, cultured on Man8GlcNAc2 (each curve shows 
the mean + s.d. of 3 separate cultures). 
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Extended Data Fig. 8. Metagenomic analysis of the occurrence of the yeast mannan 
PULs in humans. Abundance of Bacteroides mannan PULs in human from a survey of 
metagenomic sequencing data from a total of 250 adult human samples (211 healthy, 27 
ulcerative colitis, 12 Crohn’s Disease; see Methods for references).  Datasets were 
individually queried by BLAST using either each entire mannan PUL (PULs 2,3) or a sub-
fragment that was trimmed to eliminate cross-detection of other species genomes beyond Bt 
and porcine B. xylanisolvens (PUL1; see Methods for additional search details). Each 
horizontal line represents the presence of a hit in a single individual. The leftmost column 
summarizes the total mannan PUL content in each person (annotated according to the color 
key in the upper right corner). The mannan PUL frequency across all 250 samples is shown 
at the bottom for each condition and is compared to the frequency of several other PULs 
implicated in xyloglucan and porphyran utilization. Graph at far right illustrates the variation 
in sequencing depth for each sample/study: black lines show the average depth in 
megabasepairs (Mbp) for each study; the light gray line shows the depth for each individual 
sample. 
 
Extended Data Fig. 9. Presence of a conjugative transposon (cTn) that harbors PUL-
Man1 in the genomes of porcine B. xylanisolvens strains and the mannan presented 
to these organisms. a, shown across the top is a schematic of a cTn that has been 
integrated into the 3' end of a tRNAphe gene in Bt strain VPI-548243. Integration is mediated 
by a 22 bp direct repeat sequence that is contained in tRNAphe and repeated again at the 
other side of the cTn (insertion site right). The location of Bt PUL-Man1 is denoted within the 
larger cTn element using a colour scheme identical to Fig. 1a. The lower panel shows an 
expanded view of the PUL-Man1 locus in five sequenced strains of B. xylanisolvens from the 
feces of pigs fed a diet enriched with distillers grains that were fermented with yeast. A 
nearly identical copy (both by amino acid homology and syntenic organization) of this 
genomic region is present in Bt and the porcine B. xylanisolvens strains. Although the draft 
genomes of the B. xylanisolvens strains contains gaps in all 5 assemblies at the left side of 
the PUL-Man1, the right side insertion site was resolved in all genomes, suggesting that the 
B. xylanisolvens loci were also transferred by lateral transfer at some point in the history of 
these strains. b, 43 different strains from five Bacteroidetes isolated from animal guts (each 
indicated with a solid circle) were inoculated into minimal media containing S. cerevisiae 
mannan as the sole carbon source. The growth of the cultures was measured over 48 h by 
recording the optical density at 600 nm. c, TLC analysis of the products generated by 
incubating BT3774 and BT3792 with -mannan extracted from the distillers grain fed to the 
pigs from which the B. xylanisolvens were isolated. The data are representative of two 
technical replicates. 
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Extended Data Fig. 10. In vivo and in vitro expression of the mannan PULs. a, level of 
susC-like transcripts derived from PUL-Man1 (BT2626), PUL-Man2 (BT3788) and PUL-
Man3 (BT3854) from Bt in monocolonized gnotobiotic mice fed a "glycan-free" diet deficient 
in Bt-digestible glycans (red), the same diet with added yeast mannan (1% w/v in drinking 
water) as the only usable polysaccharide (green), and a diet containing 50% bread (blue). 
The levels of the susC transcripts were quantified relative to the same mRNA species in Bt 
cultured in vitro on glucose minimal medium (MM-G). Note that in all cases, expression of 
PUL-Man genes is equally high in vivo. b, transcription of the same mannan susC-like genes 
in response to increasing concentrations of yeast mannan in the media after 30 min 
exposure. The prototypic susC (BT3701) involved in starch metabolism is shown for 
comparison. c, an identical exposure experiment to that shown in Panel B, except that 
glucose-grown Bt cells were exposed to aqueous extracts of the cereal grain diet (natural 
diet) fed to mice prior to the experiment, or the digestible glycan free control diet (glycan-free 
diet) used as a base for all feeding treatments. Exposure was conducted for 30 min to 
determine if any diet extract contained contaminating levels of mannan that could be 
detected by Bt cells; inclusion of purified mannan (5 mg/ml) in addition to the glycan-free diet 
serve as positive controls. In all panels, the results represent the mean of 3 biological 
replicates and error bars represent s.d.  
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